U.S. EPA Approves Expanded Use of LEAP® ES Bacterial Disease Management Biological Insecticide from Valent BioSciences

FOR IMMEDIATE RELEASE

LIBERTYVILLE, Ill., February 1, 2022 – Valent BioSciences has announced that the U.S. EPA (Environmental Protection Agency) has approved the expanded use of LEAP® ES Bacterial Disease Management Biological Insecticide. As a result of this approval, LEAP ES is now registered for preventative use against cabbage Black Rot and Goss’s Wilt in sweet corn. It was approved previously for use on tomatoes and peppers.

LEAP ES features a distinctive mode of action and is the only alternative to copper-based products that, as part of a program, delivers two-way protection from both bacterial diseases and lepidopteran larvae that can reduce crop quality and yield.

The product triggers plant defenses to minimize effects from bacterial diseases while controlling yield-diminishing lepidopteran larvae that can increase pathogen points of entry. LEAP ES contains methyl salicylate (MeSA), a powerful plant compound that elicits a plant’s natural defense systems against pathogen infections without reducing crop yield.

“This expanded registration means that more growers will be able to utilize LEAP ES to control bacterial disease and worm problems on their crops,” said Rosa Gimenez, Valent BioSciences’ Global Business Director, Biorational Crop Protection. “LEAP ES offers a proven and effective biorational product solution that is ideal for the needs of today’s growers.”

LEAP ES is available through Valent U.S.A.’s extensive distribution network.

Click here to learn more about LEAP ES Bacterial Disease Management Biological Insecticide.

###

About Valent BioSciences LLC

Headquartered in Libertyville, Illinois, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Co., Ltd., and is the worldwide leader in the development, manufacturing, and commercialization of biorational products with sales in 95 countries around the world. Valent BioSciences is an ISO 9001 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

Media Contact:

John Mandel
Valent BioSciences LLC
+1-847-968-4728
Email: john.mandel@valentbiosciences.com

Download Press Release

Share:

Related News

WHITE CITY, Ore., September 21, 2023 – To meet the increasing demands and...
Broadening its commitment to sustainability and corporate social value, Valent BioSciences LLC formally dedicated a new prairie park and solar field adjacent to its manufacturing facility in Osage, Iowa, on June 24.
The Pest Management Regulatory Agency (PMRA) recently approved, for the first time, drone use as an application method for three Public Health products from Valent BioSciences LLC.
Valent BioSciences LLC, a global leader in the discovery, development, and commercialization of highly effective, low-risk, environmentally compatible technologies and products for agriculture, public health, and forest health, announces the retirement of President and CEO Ted Melnik, effective July 2023. In addition, Salman Mir, currently Executive Vice President and Chief Operating Officer, has been named President and CEO, also effective July 2023.
Valent BioSciences LLC announces its acquisition of FBSciences Holdings, Inc., a leader in the discovery and commercialization of naturally derived plant, soil, and climate health solutions.
The new solar field at Valent BioSciences’ manufacturing facility in Osage, Iowa, is now fully operational.